Hyundai Pharmaceutical

현대약품 · 004310

Health Care Pharmaceuticals · KOSPI

Small-cap

Market cap US$147M (₩202.9B)

Overview

Hyundai Pharmaceutical makes prescription drugs, over-the-counter medicines, functional foods, and cosmetics, ranging from treatments for dementia and abnormal cholesterol levels to a well-known hair-loss remedy and a dietary-fibre drink.

It supplies hospitals, clinics, pharmacies, and wholesalers across South Korea, and is listed on KOSPI, Korea's main stock exchange. Its business spans four distinct segments, pharmaceuticals, food, cosmetics, and medical devices, with the food segment anchored by a single long-running dietary-fibre beverage brand.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025
Revenue · FY2025
US$139M
▲ +9.1% YoY
Operating profit · FY2025
US$3M
▲ +2200.3% YoY
Net income · FY2025
US$1.8M
Turned profitable

Revenue

  • FY2023US$131M
  • FY2024US$127.3M
  • FY2025US$139M

Operating profit

  • FY2023US$5M
  • FY2024US$131.1K
  • FY2025US$3M

Net income

  • FY2023US$4.4M
  • FY2024−US$416.6K
  • FY2025US$1.8M

Key ratios (FY2025)

ROE
3.1%
Debt/Eq
98.8%
Op. margin
2.2%
Net margin
1.3%
Rev. YoY
▲ +9.1%

Why it matters

The company entered the cosmetics business using in-house peptide and compound-ingredient technology developed through its own pharmaceutical research capabilities.

Price charts coming soon

Interactive price history isn't here yet. Would you use it?

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-06-12 (KST). · FX: 1 USD ≈ ₩1,380 (2026-06-01).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.